Categories: News

Franchise Global Health Inc. Announces First Day of Trading & Market Opening

NOT FOR DISSEMINATION IN THE U.S. OR THROUGH U.S. NEWSWIRES

VANCOUVER, BC / ACCESSWIRE / March 29, 2022 / Franchise Global Health Inc. (“Franchise Global” or the “Company”) (TSXV: FGH) is pleased to announce that the Company’s shares will commence trading at market open today on the TSX Venture Exchange under the symbol “FGH”. In addition, Clifford Starke, Executive Chairman and CEO of Franchise Global and his team will celebrate the Company’s new listing on the TSX Venture Exchange and open the market.

Franchise Global Executive Chairman and CEO, Clifford Starke, said: “We are extremely pleased to have successfully completed the Company’s Qualifying Transaction last week and to be opening the TSX Venture Exchange today. After an extensive period of preparation, we are now a publicly-traded, fully‑integrated cannabis company which has a clear focus on the European opportunity.

“As we enter this next stage of growth as a public company, we are confident in the prospects of the business. We would like to thank our shareholders for their continued support and we look forward to the road ahead and continued shareholder value creation.”

The listing of the common shares of the Company follows the completion of its “Qualifying Transaction”, as such term is defined under the policies of the TSX Venture Exchange, on March 25, 2022.

About Franchise Global
Franchise Global, through its subsidiaries, is a multi-national operator in the medical cannabis and pharmaceutical industries, with principal operations in Germany and with operations, assets, strategic partnerships and investments internationally. Franchise Global’s business objective is to develop a fully-integrated, leading European medical cannabis business, with the goal of providing high-quality pharmaceutical grade medical cannabis to distribution partners and, ultimately, to patients, at competitive prices.

For further information, please contact:

Franchise Global Health
Clifford Starke, Executive Chairman and CEO

Via Buchanan
www.franchiseglobalhealth.com

Media Enquiries
Buchanan
Jamie Hooper / Ariadna Peretz

Tel: +44 (0) 20 7466 5000
FGH@buchanan.uk.com

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS PRESS RELEASE.

This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction, including in the United States. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“) or any state securities laws and may not be offered or sold within the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Cautionary Statement Regarding Forward-Looking Information
This news release contains “forward-looking information” within the meaning of applicable securities laws, including without limitation statements regarding the business of Franchise Global and its prospects. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or variations (including negative variations) of such words and phrases, or statements formed in the future tense or indicating that certain actions, events or results “may”, “could”, “would”, “might” or “will” (or other variations of the foregoing) be taken, occur, be achieved, or come to pass. Forward-looking information is based on management’s current expectations, estimates, beliefs and/or opinions and is based on information currently available to them (including information obtained from third party industry analysts and other third-party sources) and on assumptions they believe not to be unreasonable in light of all of the circumstances. By its nature, forward-looking information is subject to both known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such risks and uncertainties include, without limitation, risks relating to general economic conditions, counterparty risk, regulatory factors, the financial markets generally and risks associated with growth and competition. Accordingly, readers are cautioned to not place undue reliance on forward-looking information. Please refer to the filing statement of the Company available on the Company’s SEDAR profile at www.sedar.com for more details on the risks and uncertainties faced by Franchise Global. Any and all forward-looking information contained in this news release is expressly qualified by this cautionary statement, and the Company undertakes no obligation, and does not intend, to update any forward-looking information contained in this news release, whether as a result of new information, future developments, or otherwise, except as otherwise required by applicable law.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Franchise Global Health Inc.

View source version on accesswire.com:
https://www.accesswire.com/695052/Franchise-Global-Health-Inc-Announces-First-Day-of-Trading-Market-Opening

Staff

Recent Posts

NuGen Develops Pharmacist Training Packages for the Canadian Retail Pharmacy Market

Toronto, Ontario--(Newsfile Corp. - July 9, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the…

5 hours ago

Puro Sound Labs Announces Back-to-School Sale: Promoting Audio Quality and Hearing Protection for Students

SAN DIEGO, July 9, 2024 /PRNewswire/ -- Puro Sound Labs, a leader in safe listening technology,…

5 hours ago

Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base

 Accessible, highly scalable single-cell technology expands Illumina's multiomics capabilities SAN DIEGO, July 9, 2024 /PRNewswire/ --…

5 hours ago

Nabla Rolls out at Carle Health Through Epic Integration

U.S. health systems are increasingly embracing ambient documentation solutions to reduce providers' administrative workloads and…

5 hours ago